首页> 外文OA文献 >New Approaches to Treat Osteoarthritis with Mesenchymal Stem Cells
【2h】

New Approaches to Treat Osteoarthritis with Mesenchymal Stem Cells

机译:用间充质干细胞治疗骨关节炎的新方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Osteoarthritis is one of the most common chronic health problems in the world that causes disability and chronic pain with reduced mobility and is a progressive degenerative disease in weight-bearing joints such as the knee. The pathology of the joint resulting from OA includes loss of cartilage volume and cartilage lesions leading to inflammation of the articular joint structures; its incidence and progression are associated with a variety of risk factors. Most of the current treatments focus on symptom management such as physical and occupational therapies, pharmacological intervention for pain management, and surgical intervention with limited success and do not address nor halt the progression of the disease. In this review, we will describe the current treatment options for OA and the exciting new translational medical research currently underway utilising mesenchymal stem cells for OA therapy.
机译:骨关节炎是世界上最常见的慢性健康问题之一,导致残疾和慢性疼痛降低的流动性,并且是膝关节等重量接头中的进步性退行性疾病。由OA引起的关节的病理包括丧失软骨体积和软骨病变,导致关节式关节结构的炎症;它的发病率和进展与各种风险因素有关。目前的大部分治疗都注重了物理和职业疗法,疼痛管理的药理干预以及有限的手术干预,并且没有解决,也不会停止疾病的进展。在本综述中,我们将描述OA的当前治疗方案和目前正在利用间充质干细胞进行OA治疗的令人兴奋的新翻译医学研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号